X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
infectious diseases (5) 5
adult (4) 4
hiv infections - drug therapy (4) 4
humans (4) 4
male (4) 4
viral load (4) 4
female (3) 3
hiv infections - virology (3) 3
index medicus (3) 3
middle aged (3) 3
pharmacology & pharmacy (3) 3
rna, viral - blood (3) 3
active antiretroviral therapy (2) 2
antiretroviral therapy (2) 2
article (2) 2
cd4 lymphocyte count (2) 2
controlled-trial (2) 2
drug resistance, viral (2) 2
drug therapy, combination (2) 2
infected patients (2) 2
reverse transcriptase inhibitors - adverse effects (2) 2
reverse transcriptase inhibitors - therapeutic use (2) 2
acquired immune deficiency syndrome--aids (1) 1
adenine - administration & dosage (1) 1
adenine - analogs & derivatives (1) 1
adherence (1) 1
adolescent (1) 1
africa south of the sahara (1) 1
aged (1) 1
aids/hiv (1) 1
anti-hiv agents - administration & dosage (1) 1
anti-hiv agents - adverse effects (1) 1
anti-hiv agents - therapeutic use (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - pharmacokinetics (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, neutralizing - adverse effects (1) 1
antibodies, neutralizing - therapeutic use (1) 1
antiretroviral drugs (1) 1
antiretroviral therapy, highly active (1) 1
antiviral activity (1) 1
bictegravir (1) 1
binding sites (1) 1
brazil - epidemiology (1) 1
broadly neutralizing antibodies (1) 1
carbamates - administration & dosage (1) 1
carbamates - adverse effects (1) 1
carbamates - pharmacokinetics (1) 1
cd4 antigen (1) 1
clinical trials (1) 1
clinical-trials (1) 1
co-formulated elvitegravir (1) 1
cobicistat (1) 1
combination (1) 1
complications and side effects (1) 1
cross-resistance (1) 1
dioxolanes - adverse effects (1) 1
dioxolanes - therapeutic use (1) 1
dosage and administration (1) 1
double-blind (1) 1
drug interactions (1) 1
drug-resistance (1) 1
drug-resistant hiv-1 (1) 1
emtricitabine (1) 1
failure (1) 1
fosamprenavir (1) 1
health resources - economics (1) 1
health resources - supply & distribution (1) 1
health services accessibility - economics (1) 1
historically controlled study (1) 1
hiv - genetics (1) 1
hiv - isolation & purification (1) 1
hiv antibodies (1) 1
hiv envelope protein gp41 - therapeutic use (1) 1
hiv fusion inhibitors - therapeutic use (1) 1
hiv infections - epidemiology (1) 1
hiv infections - immunology (1) 1
hiv protease inhibitors - administration & dosage (1) 1
hiv protease inhibitors - adverse effects (1) 1
hiv-1 (1) 1
hiv-1 - genetics (1) 1
hiv-1 reverse-transcriptase (1) 1
homeopathy (1) 1
human immunodeficiency virus--hiv (1) 1
human-immunodeficiency-virus (1) 1
hypersensitivity (1) 1
immunization (1) 1
immunodeficiency-virus-infection (1) 1
immunoglobulins (1) 1
immunology (1) 1
immunotherapy (1) 1
india - epidemiology (1) 1
infection (1) 1
infectious disease (1) 1
inhibitor (1) 1
inhibitors (1) 1
k65r (1) 1
lopinavir (1) 1
lopinavir - administration & dosage (1) 1
lopinavir - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 21, pp. 2037 - 2050
Journal Article
Lancet HIV, The, ISSN 2352-3018, 2016, Volume 3, Issue 6, pp. e247 - e258
Journal Article
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, ISSN 0305-7453, 05/2019, Volume 74, Issue 5, pp. 1376 - 1380
Background: The AIDS Clinical Trials Group study A5353 demonstrated the efficacy and safety of dolutegravir and lamivudine for initial treatment of HIV-1... 
INFECTIOUS DISEASES | MULTICENTER | COBICISTAT | EMTRICITABINE | CO-FORMULATED ELVITEGRAVIR | MICROBIOLOGY | PHASE-3 | TENOFOVIR ALAFENAMIDE | NAIVE PATIENTS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | INFECTION | BICTEGRAVIR
Journal Article
HIV Clinical Trials, ISSN 1528-4336, 04/2008, Volume 9, Issue 2, pp. 91 - 102
Purpose: To compare activity and safety of a regimen containing lopinavir/ritonavir (LPV/r) + fosamprenavir (FPV) to regimens with LPV/r or FPV + r and to test... 
protease inhibitors | fosamprenavir | lopinavir | antiretroviral therapy | ritonavir | Fosamprenavir | Protease inhibitors | Ritonavir | Lopinavir | Antiretroviral therapy | CONTROLLED-TRIAL | INFECTIOUS DISEASES | NAIVE HIV-1-INFECTED PATIENTS | CROSS-RESISTANCE | OPEN-LABEL | DRUG-RESISTANCE | HUMAN-IMMUNODEFICIENCY-VIRUS | LOPINAVIR-RITONAVIR | VIROLOGICAL FAILURE | ACTIVE ANTIRETROVIRAL THERAPY | PHARMACOLOGY & PHARMACY | INFECTED PATIENTS | Organophosphates - adverse effects | Humans | Middle Aged | Male | RNA, Viral - blood | Carbamates - administration & dosage | Carbamates - pharmacokinetics | Viral Load | Tenofovir | Ritonavir - adverse effects | Adult | Female | Drug Therapy, Combination | HIV Protease Inhibitors - adverse effects | Organophosphates - administration & dosage | Organophosphates - pharmacokinetics | Adenine - analogs & derivatives | Ritonavir - administration & dosage | Pyrimidinones - adverse effects | HIV Protease Inhibitors - administration & dosage | Sulfonamides - pharmacokinetics | Adenine - administration & dosage | Organophosphonates - administration & dosage | Pyrimidinones - pharmacokinetics | Ritonavir - pharmacokinetics | Adolescent | Sulfonamides - adverse effects | Carbamates - adverse effects | HIV Infections - drug therapy | Pyrimidinones - administration & dosage | Sulfonamides - administration & dosage | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.